10.1136/egastro-2023-100036 16 ChenM
And she has a personal story around weight, health, and what that meant in her life, beginning at childhood that were going to talk about
It is a dual GLP-1 and GIP receptor agonist
What are the known uncertainties, potential adverse effects, and warning signs
The Food and Drug Administration (FDA) has now approved several GLP-1 medications for chronic weight management in adults with obesity
Taken together, the findings based on polling of more than 2,000 UK shoppers suggest GLP-1 drugs are not simply reducing appetite they are reshaping taste and consumption habits, posing a longer-term challenge to categories built around indulgence, snacking and large portion sizes